{"id":"NCT00819052","sponsor":"Boehringer Ingelheim","briefTitle":"Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients","officialTitle":"An Open Label, Phase IIIb, Randomised Parallel Group Study to Assess the Efficacy and Safety of Switching HIV-1 Infected Patients Successfully Treated With a Nevirapine IR Based Regiment to Nevirapine XR 400 mg QD or Remaining on Nevirapine IR 200 mg BID Based Program","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2009-01-08","resultsPosted":"2012-02-24","lastUpdate":"2014-11-10"},"enrollment":445,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections"],"interventions":[{"type":"DRUG","name":"Nevirapine XR","otherNames":[]},{"type":"DRUG","name":"Nevirapine XR","otherNames":[]},{"type":"DRUG","name":"Nevirapine IR","otherNames":[]}],"arms":[{"label":"NVP IR","type":"ACTIVE_COMPARATOR"},{"label":"NVP XR","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to demonstrate the efficacy of nevirapine extended release (NVP XR) based regimen for HIV-1 infected patients who were receiving nevirapine immediate release (NVP IR) based regimen for at least 18 prior weeks of therapy.","primaryOutcome":{"measure":"Comparison of Virologic Response at Week 24 Using Lower Limit of Quantification (LLOQ) = 50 Copies/mL, Full Analysis Set Population","timeFrame":"week 24","effectByArm":[{"arm":"Nevirapine Immediate Release (NVP IR)","deltaMin":137,"sd":null},{"arm":"Nevirapine Extended Release (NVP XR)","deltaMin":276,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":39,"countries":["United States","France","Germany","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":148},"commonTop":["Nasopharyngitis","Diarrhoea","Bronchitis","Back pain","Upper respiratory tract infection"]}}